Reveal® Q+ for DON EndPoint
25 tests per kit
SKU No. 700002536 | Catalog No. 8375
- For use with the Raptor® Solo Platform
- Uses the standard track mode
- Easy to use for increased workflow output
| Specifications | ||
|---|---|---|
| Brand | Reveal® | |
| Analyte | Deoxynivalenol (DON) | |
| Platform | Lateral Flow | |
| Result Type | Quantitative | |
| Approvals | FGIS: 2021-154 | |
| Quantity per Package | 25 tests | |
| Package Dimensions | 8.50 in x 2.50 in x 2.50 in | |
| Package Weight | 0.47 lb | |
Technology
In the test, the extract is wicked through the reagent zone, which contains antibodies specific for DON conjugated to colloidal gold particles (gold complex). If DON is present, it will be captured by the gold complex. The gold complex, along with any free gold-complex, is then wicked onto a membrane, which contains a zone of DON conjugated to a protein carrier. This zone captures any unbound gold complex, allowing the particles to concentrate and form a visible line. As the level of DON in a sample increases, free aflatoxin will bind with the gold complex allowing the less gold complex to be captured in the test zones. Therefore, as the concentration of DON in the sample increases, the test line density decreases.
Algorithms programmed into the readers convert the line intensities into a quantitative result displayed in parts per billion (ppb). The membrane also contains a control zone where an immune complex present in the reagent zone is captured by an antibody, forming a visible line. The control line will always form regardless of the presence of DON, ensuring the strip is functioning properly.
Training
Our customers’ success is our shared success. Our experts are ready to train you and your team on our solutions, so you can rest easy knowing procedures are performed properly and yield accurate results. In addition, we provide certificates upon completion of training to provide you with the documentation needed for audit traceability.